The inhaled PDE4 inhibitor GSK256066 significantly inhibits airway responses following allergen challenge in asthmatics Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
Mechanism of protective effect of inhaled budesonide on airway response to ozone (O3) exposure Source: Eur Respir J 2004; 24: Suppl. 48, 364s Year: 2004
The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Low exposure to inhaled formaldehyde: effect on allergen bronchial response in asthmatics sensitized to mite Source: Eur Respir J 2006; 28: Suppl. 50, 592s Year: 2006
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009
Effect of combined leukotriene, histamine antagonism on the early response to inhaled allergen Source: Eur Respir J 2005; 26: Suppl. 49, 583s Year: 2005
Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma Source: Eur Respir J 2003; 21: 1046-1049 Year: 2003
The effect of GSK2190915, a 5-lipoxygenase activating protein inhibitor, on the early asthmatic response to inhaled allergen Source: Annual Congress 2011 - Asthma management and response Year: 2011
Effect of nitric oxide inhibition on immediate response to nasal allergen challenge in allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Inhaled IL-4/IL-13 antagonist decreases response to antigen challenge in atopic asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 490s Year: 2007
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Source: Eur Respir J 2004; 23: 559-564 Year: 2004
In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin Source: Eur Respir J 2004; 24: Suppl. 48, 6s Year: 2004
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis Source: Annual Congress 2011 - T-cell subsets Year: 2011
Inhibition of the inhaled allergen challenge response by the CRTH2 antagonist OC000459 in patients with asthma Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010
Effects of inhaled tussigenic aerosols on respiratory reflex responses in humans Source: Eur Respir J 2002; 20: Suppl. 38, 297s Year: 2002
Effect of inhaled salmeterol or fluticasone on organic dust induced bronchial hyperreactivity Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002
Reduced late asthmatic response by repeated low-dose allergen exposure Source: Eur Respir J 2001; 17: 872-880 Year: 2001
Inhaled diesel exhaust alters the allergen-induced bronchial secretome in humans Source: Eur Respir J, 51 (1) 1701385; 10.1183/13993003.01385-2017 Year: 2018